As a pioneer in the field of exosome therapeutics Evox has established an impressive foundational portfolio of intellectual property. Evox prides itself on having created a comprehensive IP portfolio encompassing all key aspects of exosome-based drug delivery technology.
Evox’s IP Portfolio:
The Evox IP portfolio includes granted and pending applications in all major pharmaceutical markets, including USA, Europe, Japan, China and Korea as well as many other jurisdictions. In addition, trade-secrets, know-how, copyrights and trademarks complete a broad and deep protection for the company’s intellectual assets.